Prevalence, Predictors, and Outcomes of Patients With ST-Elevation Myocardial Infarction and Angiographically

Nir Levi1, Ziv Dadon2, Yoed Steinmetz2

  • 1Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel.

Insights

Nearly 20% of ST-elevation myocardial infarction patients have significant non-infarct-related artery coronary artery disease. This condition, linked to older age, male gender, and diabetes, increases mortality risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • ST-elevation myocardial infarction (STEMI) management often focuses on the infarct-related artery (IRA).
  • However, significant coronary artery disease (CAD) in non-IRA vessels may impact patient outcomes.
  • Understanding the prevalence and predictors of non-IRA CAD in STEMI is crucial for comprehensive treatment strategies.

Purpose of the Study:

  • To determine the prevalence of angiographically significant non-IRA CAD in patients with STEMI.
  • To identify independent predictors associated with the presence of non-IRA CAD.
  • To evaluate the impact of non-IRA CAD on short- and long-term all-cause mortality.

Main Methods:

  • Retrospective analysis of consecutive STEMI patients undergoing primary percutaneous coronary intervention (2000-2020).
  • Definition of significant CAD: >50% left main stenosis or >90% stenosis in other arteries.
  • Statistical analysis to identify predictors and compare mortality rates between groups (IRA-only CAD vs. non-IRA CAD).

Main Results:

  • A total of 3,320 patients were analyzed; 19.8% (657) had significant non-IRA CAD.
  • Independent predictors for non-IRA CAD included male gender, age >50 years, and diabetes mellitus.
  • Smoking and family history of CAD were negatively associated with non-IRA CAD.
  • Patients with non-IRA CAD exhibited significantly higher in-hospital, 30-day, 1-year, and 5-year all-cause mortality rates.

Conclusions:

  • Approximately 20% of STEMI patients present with significant non-IRA CAD.
  • Older age, male gender, and diabetes are key predictors of non-IRA CAD.
  • The presence of non-IRA CAD is a significant independent predictor of increased short- and long-term mortality in STEMI patients.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
97
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
47
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
49
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
41